disorders of lipid metabolism	is a	category of metabolic disorders
hyperlipidemia	is a	disorder of lipid metabolism
hyperlipidemia	is associated with	atherosclerosis
hyperlipidemia	increases risk of	cardiovascular disease
hyperlipidemia	increases risk of	myocardial infarction
hyperlipidemia	increases risk of	stroke
hyperlipidemia	can cause	nonalcoholic fatty liver disease
hypertriglyceridemia	is a	lipid disorder
triglycerides	correlate with	pancreatitis
low-density lipoprotein	is a	lipoprotein
low-density lipoprotein	contributes to	atherosclerosis
high-density lipoprotein	is a	lipoprotein
lipoprotein(a)	associated with	cardiovascular disease
apolipoprotein B	is a	protein
apoB-containing lipoproteins	are	atherogenic particles
apoB	participates in	LDL particles
dyslipidemia	is associated with	insulin resistance
familial hypercholesterolemia	is a	genetic disorder
familial hypercholesterolemia	causes	early atherosclerosis
familial combined hyperlipidemia	is a	genetic disorder
secondary dyslipidemia	is caused by	hypothyroidism
hypothyroidism	causes	dyslipidemia
nephrotic syndrome	causes	dyslipidemia
alcohol consumption	worsens	dyslipidemia
metabolic syndrome	includes	dyslipidemia
metabolic syndrome	increases risk of	cardiovascular disease
obesity	associated with	dyslipidemia
insulin resistance	leads to	hyperlipidemia
statins	reduce	LDL
statins	decrease	cardiovascular risk
bile acid sequestrants	lower	LDL
ezetimibe	inhibits	intestinal cholesterol absorption
PCSK9 inhibitors	reduce	LDL
fibrate	lowers	triglycerides
niacin	increases	HDL
omega-3 fatty acids	lower	triglycerides
statin therapy	improves	lipid profile
lipid profile	includes	LDL
lipid profile	includes	triglycerides
lipid profile	includes	HDL
hepatic steatosis	occurs with	dyslipidemia
NAFLD	is associated with	dyslipidemia
NAFLD	progresses to	cirrhosis
cirrhosis	associated with	dyslipidemia
lipid-lowering therapy	used for	dyslipidemia
dietary modification	reduces	LDL
physical activity	improves	lipid profile
smoking	worsens	dyslipidemia
age	affects	lipid levels
gender	influences	lipid profile
genetic mutation	causes	familial hypercholesterolemia
family history	increases risk of	dyslipidemia
age	increases	risk of cardiovascular disease
smoking	increases	cardiovascular risk
exercise	lowers	triglycerides
weight loss	improves	lipid profile
dietary saturated fat	increases	LDL
dietary fiber intake	lowers	cholesterol
statin intolerance	leads to	uncontrolled hyperlipidemia
lipid metabolism defect	present in	familial hypercholesterolemia
plaque	forms due to	atherogenic lipoproteins
atherosclerosis	causes	myocardial infarction
steroid therapy	can cause	dyslipidemia
Cushing's syndrome	associated with	dyslipidemia
nephrotic syndrome	causes	hyperlipidemia
cholesterol	participates in	membrane structure
LDL receptor deficiency	causes	familial hypercholesterolemia
apolipoprotein E	involved in	lipoprotein clearance
lipids	contribute to	energy storage
dyslipidemia	diagnosed by	lipid panel
lipid panel	includes	LDL
lipid panel	includes	triglycerides
lipid panel	includes	HDL
hepatic steatosis	associated with	obesity
NAFLD	linked with	metabolic syndrome
dietary cholesterol	contributes to	serum cholesterol
serum cholesterol	reflects	dietary intake
lipid synthesis	occurs in	liver
liver	produces	cholesterol
cholesterol homeostasis	maintained by	liver
intestine	absorbs	dietary cholesterol
dietary cholesterol	absorbed by	intestine
atherogenic lipoproteins	promote	plaque formation
lipid-lowering therapy	indicated for	dyslipidemia
lipoprotein metabolism	altered in	dyslipidemia
lipid profile	abnormal in	dyslipidemia
reverse cholesterol transport	is carried by	HDL
inflammation	modulates	lipid metabolism
lipid metabolism	affected by	age
statin-associated myopathy	is a	adverse effect of statins
myopathy	can lead to	rhabdomyolysis
bempedoic acid	lowers	LDL
gallstone formation	occurs with	dyslipidemia
lipid dysregulation	exacerbated by	sedentary lifestyle
sedentary lifestyle	worsens	dyslipidemia
aging	associated with	lipid changes
statin therapy	used for	dyslipidemia
statin resistance	occurs in	dyslipidemia
dietary cholesterol	modifiable by	nutrition therapy
lipoprotein metabolism	altered in	dyslipidemia
